To Evaluate Analgesic Effect of Dexmedetomidine with Ropivacaine in USG Guided Erector Spinae Plane Block for Breast Surgery

Not Applicable

Not yet recruiting

• Conditions: Malignant neoplasm of breast of unspecified site,

• Registration Number: CTRI/2020/06/025660
• Lead Sponsor: Department of Anaesthesiology Maharana Bhupal Government Hospital

Brief Summary

i am evaluating analgesic efficacy of Dexmedetomidine as an adjuvant to Ropivacaine in USG Guided ESPB for MRM surgery. kindley considere this trial for CTRI registration.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-05-27
• Study Start: 2020-10-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

ASA Grade I and II Posted for Modified Radical Mastectomy surgery.

Exclusion Criteria

Patient refusal ASA Grade III and above Drug allergy Obese(BMI >35 kg per sq.m) Bradycardia Coagulopathy Cardiac Conduction Block Infection at Injection site patient n beta blocker or antiplatelet Psychiatric illness Chronic analgesic Use.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of analgesia	24 hour post operatively
Quality of analgesia	24 hour post operatively

Secondary Outcome Measures

Name	Time	Method
Intra operative hemodynamic	Adverse effect

Trial Locations

Locations (1)

General Surgery Operation Theater Second Floor; 🇮🇳 Udaipur, RAJASTHAN, India

General Surgery Operation Theater Second Floor

🇮🇳Udaipur, RAJASTHAN, India

Dr Krishna Boliwal

Principal investigator

9928015710

kboliwal@yahoo.com